Follow the Live #NephTrials Discussion on Spironolactone and its Impact on Dialysis Patients: Join on September 28 @ 9 p.m. EST
The #NephTrials initiative is an exciting series of conversations combining expertise from:
Join us on September 28, 2021, at 9 p.m. EST to discuss:
Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease (ACHIEVE), evaluating if spironolactone reduces heart failure and heart-related deaths in dialysis patients.
—
Discussion focus:
Run-in periods: useful or threat to generalizability and biased results?
—
| Participants: |
|
To access the discussion:
- Follow @NephJC and @ISNkidneycare
- Enter “NephTrials” in Twitter’s search bar
- Go to “latest”
- Follow the conversation
#NephTrials #NephJC
Or consult ISN’s easy-to-follow infographic here to help you join the conversation in a few clicks.
